When women think about estrogen replacement therapy, estradiol is the type of estrogen that usually comes to mind. And occasionally estrone.
But there’s a third estrogen that has mostly been left out of mainstream estrogen replacement therapy…despite decades of research suggesting it deserves a seat at the table.
We’re talking about estriol.
Estriol is the weakest of the three primary estrogens. Yet, that relative weakness is precisely what makes it so compelling—and valuable—as part of a comprehensive estrogen replacement protocol.
Understanding the Three Estrogens
The human body produces three primary estrogens:
- Estrone (E1): The dominant estrogen after menopause, primarily produced in fat tissue. Estrone is a relatively potent estrogen that has been associated with increased cancer risk when present in excess.
- Estradiol (E2): The most potent and prevalent estrogen during the reproductive years. It drives most of the beneficial effects of estrogen on the brain, bones, heart, and skin. And it’s the primary form of estrogen used in conventional HRT.
- Estriol (E3): The weakest of the three estrogens, produced in large amounts during pregnancy and in small amounts throughout a woman’s reproductive years. Estriol is the estrogen most widely ignored by mainstream medicine.
These three estrogens are not interchangeable. They bind to estrogen receptors differently, have different tissue affinities, and have entirely different profiles.
As a consequence, a comprehensive approach to estrogen replacement that considers the body’s natural estrogen ecosystem will consider all three of the above.
Why Estriol Was Left Behind
Estriol’s absence from mainstream HRT is more a story of pharmaceutical economics than science.
Because estradiol and estriol are naturally occurring substances, they cannot be patented by pharmaceutical companies. This makes both of these bioidentical estrogens less attractive for large-scale clinical trials that are funded by pharmaceutical companies.
To the extent bioidentical estrogens have been researched, estradiol (as the stronger of the two estrogens) has received most of the attention. This means the evidence base for estriol—while significant—is smaller.
This gap has left many women and clinicians unaware of estriol’s potential—not because the science isn’t there, but because the commercial infrastructure to mainstream it simply hasn’t developed.
The Benefits of Estriol
1. Relief from Genitourinary Symptoms
One of the best-established uses of estriol is the treatment of genitourinary syndrome of menopause (GSM)—which includes vaginal dryness, painful intercourse, urinary urgency, and recurrent urinary tract infections. Transdermal and vaginal estriol has shown consistent efficacy in clinical studies, restoring vaginal pH, improving tissue integrity, and reducing UTI frequency.
A landmark study published in The New England Journal of Medicine found that vaginal estriol cream significantly reduced the recurrence of UTIs in postmenopausal women. Unlike systemic estrogen, low-dose vaginal estriol largely stays local, making it an attractive option, even for women who may not be candidates for systemic HRT.
2. A Potentially Safer Estrogen Profile
Estriol’s receptor binding behavior sets it apart from estradiol and estrone. While estradiol activates both estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ), estriol shows a preferential affinity for ERβ. This distinction matters clinically, because ERα activation is associated with cell proliferation in breast and uterine tissue, while ERβ tends to have anti-proliferative effects.
In other words, estriol may carry a more favorable safety profile with respect to breast and endometrial tissue—not because it’s inert, but because of how it interacts with those tissues.
3. Neuroprotective Effects
Emerging research suggests that estriol may have neuroprotective properties relevant to both menopause management and neurological conditions. Studies have shown estriol’s ability to reduce inflammation in the central nervous system and support myelin repair—findings that have led to early clinical trials exploring estriol as an adjunct therapy in multiple sclerosis.
For menopausal women experiencing cognitive fog, mood changes, or early neurodegenerative risk, estriol’s potential neuroprotective role is an area worth watching closely.
4. Cardiovascular and Metabolic Effects
Estriol has been shown in some studies to have favorable effects on lipid profiles and arterial flexibility. While these effects are less potent than those of estradiol, they suggest that estriol contributes meaningfully to cardiovascular health when present in physiologic ratios to estradiol—reinforcing the argument for including it as part of a balanced estrogen replacement protocol, rather than relying solely on estradiol.
5. Skin, Bone, and Quality-of-Life Benefits
Estrogen receptors are present throughout a woman’s skin, and estriol has demonstrated the ability to improve skin hydration, elasticity, and thickness—effects that matter enormously to women navigating the physical changes of menopause. Some research also suggests mild bone-protective effects, though estradiol remains the more potent agent for osteoporosis prevention.
The Case for Bi-Estrogen Protocols
At Renew Youth, we have long advocated for and used compounded bi-estrogen formulations (which provide a combination of estradiol and estriol) as a way to more closely replicate the body’s natural estrogen environment.
The rationale is straightforward:
A woman’s body does not rely upon one single estrogen. During the reproductive years, all three estrogens are present in a dynamic ratio. This means that replacing estradiol only—no matter how carefully dosed—translates to being an oversimplification of treatment that creates gaps in efficacy and safety.
Adding estriol to estradiol when replacing estrogen can:
- Temper the proliferative effects of estradiol and estrone on breast and uterine tissue.
- Provide additional relief from genitourinary and skin-related symptoms.
- Contribute to neuroprotective and anti-inflammatory effects.
- Create a more physiologically complete estrogen milieu.
Critics argue that the evidence base for combined protocols is not yet robust enough for mainstream adoption. That is a fair point—but this cuts both ways. The absence of large-scale trials on estriol combinations is largely a function of funding priorities, not a reflection of actual utility. Because the mechanistic rationale is sound, the clinical expertise of prescribers who have been spearheading the use of estriol within estrogen replacement protocols is what’s paving the way forward.
What the Research Says (and What It Doesn’t Say)
As noted above, the research base for estriol is smaller than for estradiol, particularly regarding long-term systemic use. Most high-quality studies on estriol have focused on vaginal application, where systemic absorption is minimal. Evidence for transdermal estriol within comprehensive HRT protocols is largely observational, mechanistic, or extrapolated from European clinical experience.
What we can say with confidence is the following:
- Estriol is safe and effective for genitourinary symptoms when used vaginally.
- Its receptor binding profile suggests a more favorable safety margin relative to breast and endometrial tissue compared to using estradiol alone.
- It has biologically plausible benefits for the brain, skin, and cardiovascular system.
- It has been used therapeutically in Europe for decades without any alarming safety signals (and at Renew Youth for nearly 30 years).
- It is not a substitute for estradiol—it is a complement to it.
What remains to be fine-tuned through further research and long-term use is optimal dosing, optimal methods of delivery, and optimal ratio of estriol relative to other estrogens within systemic estrogen replacement protocols.
The Bottom Line
Estriol is not a fringe concept. Rather, it’s a naturally occurring hormone that has been used medicinally for generations, studied in peer-reviewed literature, and prescribed by clinicians around the world. Its relative absence from mainstream use within the U.S. is a regulatory and commercial artifact, rather than a scientific verdict.
For women seeking estrogen replacement that goes beyond the one-size-fits-all model, estriol is an important piece of the puzzle…with a growing body of researchers believing estrogen replacement should look more like what the body makes naturally during younger years—a nuanced blend of estrogens working in concert—rather than a single molecule standing in for a complex system.
As personalized medicine continues to evolve, and the conversation around women’s hormone health deepens, estriol deserves not just a second look, but a permanent place in the clinical conversation.
Your hormones deserve more than a surface-level approach. At Renew Youth, we’ve been providing physician-supervised estrogen replacement therapy (that includes estriol) since 1999. Call us at (800) 859-7511 or use our easy contact form to schedule your complimentary 30-minute consultation.